US Open: Wall Street tries to extend growth momentum 📈Tesla gains 2.5%

6:00 PM 10 June 2025

So far, very limited comments from the U.S.-China talks suggest positive progress, as indicated by both sides. The market remains optimistic about the outcome of the bilateral negotiations, viewing them as an almost “sure thing” signaling a “de-escalation” of the trade war. White House spokesperson Johnson mentioned that reconciliation between Trump and Musk might occur; Tesla shares are attempting to recover losses, rising 2.5% today.

  • Sentiment on the U.S. stock market remains very solid; the US500 and US100 indices are gaining between 0.1% and 0.2%, both hovering near all-time highs.
  • NFIB data suggests improving sentiment among small U.S. business owners (May reading 98.8 vs. 96 and 95.5 previously).
  • Sales at large U.S. department stores rose 4.7% year-over-year in May, according to Redbook data; April’s reading was 4.9% year-over-year.
  • U.S.-China talks continue; negotiators resumed discussions about 1 PM GMT after a short break. There are still no concrete details or significant “leaks” to the media.
  • An economist survey implies GDP growth of 1.4% in 2025 and 1.5% in 2026; over 60% expect at least two rate cuts this year; 59 out of 105 economists indicate the Fed will begin cuts in September.
  • The World Bank lowered its U.S. GDP growth forecast for 2025 by 0.9 percentage points to 1.4% year-over-year and by 0.4 percentage points for 2026.

US500 (Daily Chart)

The S&P 500 futures contract (US500) is up 0.2% after the session opened, but bulls still face fairly strong selling pressure that is currently holding back a breakout. If the index manages to rise above 6050 points, the path to testing historical highs appears open.
Źródło: xStation5
Source: xStation5

Start investing today or test a free demo

Create account Download mobile app Download mobile app

US100 (4-Hour Chart)

US100 remains in an uptrend, trading above both the 25-period and 50-period exponential moving averages (EMA). However, the index struggles to break through the key resistance level at 21,870 points.

Source: xStation

Apple Cuts iPhone Sales Forecast

At its developer conference, Apple mainly showcased visual updates (“Liquid Glass”), a new gaming hub, and a fitness tool rather than breakthrough AI innovations. iPhone sales forecasts were lowered by 2–3%.

  • The company emphasized better software compatibility with its advanced in-house chips and easier integration across devices (iPhone, iPad, Mac).
  • Apple faces regulatory risks: a U.S. court may block a $20 billion-per-year deal with Google, and the company can no longer collect commissions on certain in-app payments.
  • Geopolitical tensions are escalating — Trump’s trade policies are forcing Apple to move production from China to the U.S.; shares have fallen 20% since the start of the year, representing roughly $750 billion in lost market value.

Company News

  • Brown & Brown.US (BRO.US): Shares loses 1% after announcing the acquisition of Accession Risk Management Group for a staggering $9.825 billion.

  • Gryphon Digital Mining Inc.US (GRYP.US): Stock drops 2.5% following the release of financial reports for American Bitcoin Corp., linked to Trump.

  • Insmed.US (INSM.US): Shares surge 25% after positive test results for an inhalation powder drug treating lung disease.

  • McDonald’s.US (MCD.US): Redburn downgraded the fast-food giant from “buy” to “sell.” Shares fall slightly as analysts warn that weight-loss drugs are curbing customer appetites, posing a long-term threat to McDonald’s business.

  • Tencent Music ADRs.US (TME.US): Shares jumps more than 2% following news of acquiring podcast startup Ximalaya.

  • Tesla.US (TSLA.US): Shares rose 2.2% in premarket, continuing a rebound after a selloff triggered by the Musk-Trump feud. As for now, the stock is up almost 2.5%.

Apple (D1 interval)

Apple shares are still below EMA200 resistance zone, pressured by recent news.

Source: xStation5

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

Share:
Back

Join over 1 600 000 investors from around the world

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital.XTB is regulated by the SCA

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital.XTB is regulated by the SCA

The financial instruments we offer are risky. XTB is regulated by the DFSA.